jyongbio.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi MENS
The specific nature of the botanical R&D cycle complicates drug releases, yet success in urology and expense control maintain the stability of Jyong Biotech Ltd (MENS). Absolute EBITDA reflects current cash flow dynamics, where the parameter value reaches 0.00. These figures are based on the development of safe plant-based medications for prostate treatment without side effects.
Ringkesan rincian data analitis Jyong Biotech (MENS)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Jyong Biotech Ltd|MENS - Utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Jyong Biotech Limited|MENS - Gunggung utang perusahaan|Utang-utang marang nilai buku Jyong Biotech|MENS - Utang jangka dawa perusahaan|Utang jangka cendhak Jyong Biotech|Rasio likuiditas darurat jyongbio.com
- statistik bathi lan rasio pasar:
MENS - Bathi resik|Proyeksi bathi resik Jyong Biotech Ltd|MENS - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi jyongbio.com|MENS - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Jyong Biotech|MENS - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Jyong Biotech|MENS - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan jyongbio.com|MENS - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Jyong Biotech Ltd
- indikator pendapatan dodolan lan penghasilan bisnis:
Pambiji fundamental perusahaan:Jyong Biotech Ltd
This indicator tracks daily cash flow from core operations before depreciation, interest, and taxes, allowing for an assessment of the business's actual operational efficiency. By analyzing the level of net operating income before depreciation, an investor can see the ability of Jyong Biotech Ltd (MENS) to fund its R&D team and hire compliance specialists using its own resources without increasing its debt load.
Pesaing Jyong Biotech Ltd (MENS)
Haleon Corp (HLN) - Bathi sadurunge bunga, pajak, lan amortisasi|KVUE: Bathi operasional sadurunge ngurangi amortisasi|veronapharma.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|LGND: Bathi operasional EBITDA|Amneal Pharmaceuticals, Inc. - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|PRGO (Perrigo Company) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Alvotech Biopharmaceuticals ALVO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Liquidia Corporation (LQDA)|GLPG (glpg.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi ANI Pharmaceuticals, Inc. ANIP|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi MNKD (MannKind Corp)|AMPH: Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Pacira Corp|ARS Pharmaceuticals (SPRY) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi theravance.com (TBPH)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Aquestive Therapeutics, Inc.|Bathi operasional sadurunge amortisasi SCPH (scPharma)|Bathi operasional EBITDA TECX|Tonix Pharmaceuticals Holding (TNXP) - Bathi operasional sadurunge potongan amortisasi|China SXT Pharmaceuticals, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi EPRX|BioHarvest Sciences Inc. - Bathi operasional EBITDA|EXOZ: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|ORMP: Bathi operasional EBITDA|ENTX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi MindWalk Holdings|Bathi sadurunge bunga, pajak, lan amortisasi abvcpharma.com ABVC|Bathi operasional sadurunge ngurangi amortisasi CPIX (Cumberland Pharmaceuticals Inc.)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi QNTM|Bathi operasional EBITDA FGEN (FibroGen Corp)|Telomir Pharmaceuticals Corp (TELO) - Bathi sadurunge bunga, pajak, lan amortisasi|Rani Therapeutics Inc - Bathi operasional EBITDA|Synergy CHC Corp (SNYR) - Bathi operasional sadurunge ngurangi amortisasi|RLYB: Bathi operasional EBITDA|Lexaria Bioscience Corp. - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi PULM|PTHL: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Aptorum Group Limited (APM)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi LYRA (lyratherapeutics.com)|Impact BioMedical - Bathi operasional sadurunge ngurangi amortisasi|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi TNFA (TNF Pharmaceuticals Inc.)|cbdMD Corp - Bathi operasional EBITDA|PRFX (PainReform Corp) - Bathi operasional sadurunge amortisasi|altamiratherapeutics.com (CYTO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge ngurangi amortisasi lipella.com|OPTN (OptiNose) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Pieris Pharmaceuticals Inc PIRS|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Procaps Group SA (PROC)|Petros Pharma - Bathi operasional sadurunge amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Qilian International QLI|Pendapatan operasional sadurunge ngurangi amortisasi acelyrin.com (SLRN)|TFFP - Bathi sadurunge mbayar bunga, pajak, lan amortisasi
